Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2018 Aug 29

PMID 30149598

Citations 27

Authors

Juan-Carlos Saiz

Nereida Jimenez de Oya

Ana-Belen Blazquez

Estela Escribano-Romero

Miguel A Martin-Acebes

Affiliations

Soon will be listed here.

Abstract

Zika virus (ZIKV), a mosquito-borne flavivirus, was an almost neglected pathogen until its introduction in the Americas in 2015, where it has been responsible for a threat to global health, causing a great social and sanitary alarm due to its increased virulence, rapid spread, and an association with severe neurological and ophthalmological complications. Currently, no specific antiviral therapy against ZIKV is available, and treatments are palliative and mainly directed toward the relief of symptoms, such as fever and rash, by administering antipyretics, anti-histamines, and fluids for dehydration. Nevertheless, lately, search for antivirals has been a major aim in ZIKV investigations. To do so, screening of libraries from different sources, testing of natural compounds, and repurposing of drugs with known antiviral activity have allowed the identification of several antiviral candidates directed to both viral (structural proteins and enzymes) and cellular elements. Here, we present an updated review of current knowledge about anti-ZIKV strategies, focusing on host-directed antivirals as a realistic alternative to combat ZIKV infection.

Citing Articles

Advances and Challenges in Antiviral Development for Respiratory Viruses.

De Jesus-Gonzalez L, Leon-Juarez M, Lira-Hernandez F, Rivas-Santiago B, Velazquez-Cervantes M, Mendez-Delgado I Pathogens. 2025; 14(1).

PMID: 39860981 PMC: 11768830. DOI: 10.3390/pathogens14010020.

Dengue virus exploits the host tRNA epitranscriptome to promote viral replication.

Chan C, Sze N, Suzuki Y, Ohira T, Suzuki T, Begley T bioRxiv. 2023; .

PMID: 37986976 PMC: 10659268. DOI: 10.1101/2023.11.05.565734.

Lipid droplets in Zika neuroinfection: Potential targets for intervention?.

Dias S, Cunha-Fernandes T, Soares V, de Almeida C, Bozza P Mem Inst Oswaldo Cruz. 2023; 118:e230044.

PMID: 37820117 PMC: 10566564. DOI: 10.1590/0074-02760230044.

Proposal of Model for Evaluation of Viral Kinetics of African/Asian/Brazilian- Strains (Step Growth Curve) in Trophoblastic Cell Lines.

Barbosa M, Costa A, Prieto-Oliveira P, Andreata-Santos R, Peter C, Zanotto P Viruses. 2023; 15(7).

PMID: 37515134 PMC: 10386092. DOI: 10.3390/v15071446.

New Anti-Flavivirus Fusion Loop Human Antibodies with Zika Virus-Neutralizing Potential.

Franca R, Silva J, Rodrigues L, Sokolowskei D, Brigido M, Maranhao A Int J Mol Sci. 2022; 23(14).

PMID: 35887153 PMC: 9321016. DOI: 10.3390/ijms23147805.

References

Liu S, DeLalio L, Isakson B, Wang T . AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus. Circ Res. 2016; 119(11):1183-1189. PMC: 5215127. DOI: 10.1161/CIRCRESAHA.116.309866. View

Grant A, Ponia S, Tripathi S, Balasubramaniam V, Miorin L, Sourisseau M . Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe. 2016; 19(6):882-90. PMC: 4900918. DOI: 10.1016/j.chom.2016.05.009. View

Perera R, Riley C, Isaac G, Hopf-Jannasch A, Moore R, Weitz K . Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog. 2012; 8(3):e1002584. PMC: 3310792. DOI: 10.1371/journal.ppat.1002584. View

Haviernik J, Stefanik M, Fojtikova M, Kali S, Tordo N, Rudolf I . Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Viruses. 2018; 10(4). PMC: 5923478. DOI: 10.3390/v10040184. View

Pastorino B, Nougairede A, Wurtz N, Gould E, de Lamballerie X . Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs. Antiviral Res. 2010; 87(3):281-94. DOI: 10.1016/j.antiviral.2010.04.014. View

Li Y, Zhang Z, Phoo W, Loh Y, Li R, Yang H . Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor. Structure. 2018; 26(4):555-564.e3. DOI: 10.1016/j.str.2018.02.005. View

Chung D, Golden J, Adcock R, Schroeder C, Chu Y, Sotsky J . Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State. Antimicrob Agents Chemother. 2016; 60(8):4552-62. PMC: 4958224. DOI: 10.1128/AAC.00282-16. View

Xu M, Lee E, Wen Z, Cheng Y, Huang W, Qian X . Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat Med. 2016; 22(10):1101-1107. PMC: 5386783. DOI: 10.1038/nm.4184. View

Goebel S, Snyder B, Sellati T, Saeed M, Ptak R, Murray M . A sensitive virus yield assay for evaluation of Antivirals against Zika Virus. J Virol Methods. 2016; 238:13-20. DOI: 10.1016/j.jviromet.2016.09.015. View

10.

Arbuckle J, Gardina P, Gordon D, Hickman H, Yewdell J, Pierson T . Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens. mBio. 2017; 8(4). PMC: 5559635. DOI: 10.1128/mBio.01141-17. View

11.

Menendez-Arias L, Richman D . Editorial overview: antivirals and resistance: advances and challenges ahead. Curr Opin Virol. 2014; 8:iv-vii. PMC: 7129102. DOI: 10.1016/j.coviro.2014.08.002. View

12.

DICK G, KITCHEN S, HADDOW A . Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952; 46(5):509-20. DOI: 10.1016/0035-9203(52)90042-4. View

13.

Kuno G, Chang G . Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 2007; 152(4):687-96. DOI: 10.1007/s00705-006-0903-z. View

14.

Wang S, Hong S, Deng Y, Ye Q, Zhao L, Zhang F . Transfer of convalescent serum to pregnant mice prevents Zika virus infection and microcephaly in offspring. Cell Res. 2016; 27(1):158-160. PMC: 5223229. DOI: 10.1038/cr.2016.144. View

15.

Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A . A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. mBio. 2017; 8(3). PMC: 5414005. DOI: 10.1128/mBio.00452-17. View

16.

Barbosa-Lima G, Moraes A, Araujo A, da Silva E, de Freitas C, Vieira Y . 2,8-bis(trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine. Eur J Med Chem. 2017; 127:334-340. DOI: 10.1016/j.ejmech.2016.12.058. View

17.

Chen J, Yang Y, Yang Y, Zou P, Chen J, He Y . AXL promotes Zika virus infection in astrocytes by antagonizing type I interferon signalling. Nat Microbiol. 2018; 3(3):302-309. DOI: 10.1038/s41564-017-0092-4. View

18.

Kuno G, Chang G, Tsuchiya K, KARABATSOS N, Cropp C . Phylogeny of the genus Flavivirus. J Virol. 1998; 72(1):73-83. PMC: 109351. DOI: 10.1128/JVI.72.1.73-83.1998. View

19.

Jagger B, Miner J, Cao B, Arora N, Smith A, Kovacs A . Gestational Stage and IFN-λ Signaling Regulate ZIKV Infection In Utero. Cell Host Microbe. 2017; 22(3):366-376.e3. PMC: 5647680. DOI: 10.1016/j.chom.2017.08.012. View

20.

Duan W, Song H, Wang H, Chai Y, Su C, Qi J . The crystal structure of Zika virus NS5 reveals conserved drug targets. EMBO J. 2017; 36(7):919-933. PMC: 5376968. DOI: 10.15252/embj.201696241. View